Susquehanna International Group
NDRA icon

Susquehanna International Group’s ENDRA Life Sciences NDRA Stock Holding History

Susquehanna International Group’s Portfolio NDRA Stock Details NDRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-22
Closed -$3.67K – 12664
2024
Q2 		$3.67K Buy
+22
New +$9.47K ﹤0.01% 11831
2023
Q2 		– Sell
-7
Closed -$28.7K – 12768
2023
Q1 		$28.7K Buy
+7
New +$47.5K ﹤0.01% 11929
2020
Q2 		– Sell
-2
Closed -$38K – 10641
2020
Q1 		$38K Buy
+2
New +$92.7K ﹤0.01% 9768
2019
Q4 		– Hold
0
– – – 9484
2019
Q3 		– Hold
0
– – – 9992
2018
Q2 		– Hold
0
– -$40K – 10118
2018
Q1 		– Hold
0
– – – 9017

Other funds holding NDRA

VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $7.5B AUM 33.9% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Susquehanna International Group's NDRA Position: Q3 2024 in Review

Susquehanna International Group sold out of ENDRA Life Sciences (NDRA) in Q3 2024, closing a stake of 22 shares — an estimated $3.67K sold.

Susquehanna International Group first reported a position in NDRA in Q1 2020 and held it in 3 quarters. The position peaked at $38K in Q1 2020. 9 funds tracked by Wall St. Rank hold NDRA as of Q3 2024.

  • Susquehanna International Group reported no remaining ENDRA Life Sciences position as of Q3 2024 after selling out during the quarter.
  • Susquehanna International Group sold 22 ENDRA Life Sciences shares in Q3 2024, an estimated $3.67K.
  • Susquehanna International Group first reported a position in ENDRA Life Sciences in Q1 2020 and held it in 3 quarters.
  • Susquehanna International Group's ENDRA Life Sciences position peaked at $38K in Q1 2020.
  • 9 funds tracked by Wall St. Rank held ENDRA Life Sciences as of Q3 2024.

Based on Susquehanna International Group's 13F filing for Q3 2024, filed 14 Nov 2024.